Weekly Tech+Bio Highlights #64: Eli Lilly Reaches $1 Trillion Valuation

Merck's $3B AI drug discovery deal, new open-source virtual cell initiative, AI designing full-length antibodies, Europe’s first agentic AI infrastructure for biology & more

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: